Table 2.
The alteration of glucose levels in vaccinated people living with diabetes
Baseline (n = 131) |
After I dose (n = 131) |
After II dose (n = 131) |
After III dose (n = 77) |
p-value | |||
---|---|---|---|---|---|---|---|
p-value* | p-value** | p-value*** | |||||
FBG (mmol/L) | 6.51 ± 1.04 | 6.39 ± 0.98 | 6.78 ± 1.24 | 6.41 ± 1.30 | 0.241 | 0.802 | 0.027 |
PBG (mmol/L) | 8.32 ± 1.97 | 7.94 ± 1.61 | 8.02 ± 1.73 | 7.97 ± 1.64 | 0.177 | 0.523 | 0.826 |
HbA1c (%) | 6.56 ± 0.95 | - | 6.35 ± 0.87 | - | 0.012 |
FBG Fasting blood glucose, PBG Postprandial blood glucose, glycosylated hemoglobin A1c, HbA1c
*Baseline vs. after first dose
**After first dose vs. after second dose
***After second dose vs. after third dose